CH6060 - Advanced Pharmacology (2017/18)
| Module specification | Module approved to run in 2017/18 | ||||||||||||
| Module title | Advanced Pharmacology | ||||||||||||
| Module level | Honours (06) | ||||||||||||
| Credit rating for module | 15 | ||||||||||||
| School | School of Human Sciences | ||||||||||||
| Total study hours | 300 | ||||||||||||
|
|||||||||||||
| Assessment components |
|
||||||||||||
| Running in 2017/18(Please note that module timeslots are subject to change) |
|
Module summary
This module reviews the pharmacological treatments of specified human illnesses and explores the underlying cellular and molecular mechanisms involved.
Prior learning requirements
CH5011 Drugs: Delivery and Actions
Module aims
The aims of this module are aligned with the qualification descriptors within the Quality Assurance Agency’s Framework for Higher Education Qualifications.
The module aims to give an understanding of how chemical mediators affect the major organ systems of the body and explain the effects of such mediators at tissue, cellular and molecular levels with reference to disease states. It will give students experience at analysing, and drawing conclusions from, pharmacological data. It will thereby provide students with knowledge and capabilities required by pharmacologists.
Syllabus
The pharmacological treatment of diseases of key organ systems will be explored, notably the cardiovascular, pulmonary, gastrointestinal, and genitourinary systems. In addition, there will be coverage of treatments of bone disorders, cancers, and infection. Possible future pharmacogenomic treatment strategies will be explored. With regard to pharmacological therapies in general, attention will be paid to notable adverse reactions to specific drugs.
Learning and teaching
The module is delivered through a blend of directed learning sessions including lectures, tutorials, and practicals, and through the use of self-managed learning involving on-line learning materials, formative assessments, and preparation for directed sessions.
Learning outcomes
On successful completion of this module students will be able to:
1. Explain pharmacological treatments of key human disorders at the cellular and molecular level;
2. Compare and contrast available pharmacological treatments for specified disorders;
4. Critically discuss likely adverse reactions induced by specified drug therapies;
5. Critically analyse and interpret pharmacological data.
Assessment strategy
The module will be summatively assessed using a time-constrained assessment and coursework.
There will be one in-class test (1.5h) designed to demonstrate achievement of learning outcomes relating to the therapeutic use of drugs in the treatment of disease, which will take place at the end of the module. Coursework will consist of a datasheet to be completed following the collection and analysis of pharmacological data. The two coursework will also be used to provide formative feedback.
To pass the module, students need to achieve a minimum aggregate mark of 40%. There will be an attendance requirement for the practical sessions. If the module is passed on reassessment, then the maximum mark awarded will be 40%.
| Assignment | Learning Outcomes |
| Datasheet (1500 words) | 4 |
| In-class Test (1.5h) | 1,2,3 |
Bibliography
Brunton, L, Chabner, BA, Knollman, B. (2011). Goodman and Gilman’s The Pharmacological Basis of Therapeutics (12th edition). McGraw-Hill.
Galbraith, A, Bullock, S, Manias, E, Hunt, B, Richards, A. (2007). Fundamentals of Pharmacology (2nd edition).
Rang, HP, Dale, MM, Ritter, JM, Flower, RJ, Henderson G. (2011). Rang and Dale’s Pharmacology (7th edition). Churchill-Livingston.
Katzung, BG, Masters, SB, Trevor, AJ (2009). Basic and Clinical Pharmacology (11th edition). McGraw-Hill.
Plus on-line material - see the WebLearn site for details.